administration of saralasin , an angiotensin ii antagonist , not only prevented the compensation in ap , but also significantly magnified the maximal hypotensive response seen following d ( ch2 ) 5vdavp ( group 4 ) .
C0036193
saralasin
C0003009
angiotensin